您当前的位置:国际号刊-季刊 > 维普 > 五官科学 >
眼科学年鉴(英文)(Annals of Eye Science)(国际刊号)

眼科学年鉴(英文)(Annals of Eye Science)(国际刊号) 维普

基本信息
  • 主管单位:

  • 主办单位:

    中山大学中山眼科中心

  • 国际刊号:

    2520-4122

  • 国内刊号:

  • 学科分类:

    五官科学

  • 字数:

    14000-28000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    国际号刊-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

  • 邮箱:

    aes@amegroups.com(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    维普

  • 级别:

期刊简介

《眼科学年鉴(英文)(Annals of Eye Science)(国际刊号)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、该刊只有国际刊号。

2、投稿方式:在线投稿。

3、刊内网址(202401期):https://aes.amegroups.com/

4、主办单位官网:

https://www.gzzoc.com/node/99

(中山大学中山眼科中心)

5、官网邮箱:aes@amegroups.com

6、出刊日期:季刊,逢季末月出版。

2024年5月23日星期四

《眼科学年鉴(英文)》简介

(Annals of Eye Science)

【主办单位官网信息】

AES简介:

·中山大学中山眼科中心创办的国际性英文眼科学术期刊

·亚非眼科学会(AACO)官方合作期刊

·名誉主编:吴乐正教授、葛坚教授

·主编:刘奕志教授

·执行主编:林浩添教授

·编委团队:来自17个国家的85位专家组成

·宗旨:为国内外同行提供一个涵盖眼科疾病相关领域内最新研究、前沿知识和实践经验的国际性专业平台

·2021年6月:被Scopus 数据库收录

·为开放获取(OA)、同行评审的国际英文医学期刊

·网站: http://aes.amegroups.com

·邮箱: aes@amegroups.com

《眼科学年鉴(英文)》作者指南

(Annals of Eye Science)

【官网信息】

Guidelines for Authors

Thank you for your interest in the Annals of Eye Science (AES, Ann Eye Sci, Online ISSN: 2520-4122). AES adheres to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE) (1), and the Cope of Conduct and Best Practice Guidelines for Journal Editors (2), issued by the Committee on Publication Ethics (COPE). Please refer to the following guidelines to help you prepare your manuscript. Feel free to contact the editorial office by email (aes@amegroups.com) should you have any questions. To ensure a swift peer review and publication process, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision at preliminary review.

1. ABOUT THE JOURNAL

Annals of Eye Science (AES, Ann Eye Sci, Online ISSN: 2520-4122) is an international, open access, peer-reviewed online journal featuring clinical investigations, clinical observations, and clinically relevant laboratory investigations in the broad fields of ophthalmology. Specific areas of interest include, but not limited to, multimodality therapy, biomarkers, imaging, biology, pathology, and technical advances related to ophthalmology.

The aim of this journal is to provide a forum for the dissemination of current and practical information on diagnosis, prevention and basic and clinical investigations related to ophthalmology. Contributions pertinent to ophthalmology are also included from related fields such as nutrition, surgery, public health, human genetics, basic sciences, education, sociology, and nursing.

2. MANUSCRIPT CATEGORIES

2.1 Original Article

Word limit: there is no fixed word limit for research articles, but authors must use the most concise language possible, as well as succinct, structured sentences. The word count for the main text (excluding the abstract, references, tables, boxes, or figures) should be provided when the manuscript is submitted.

Abstract: Structured (usually into four paragraphs with the following subheadings: Background, Methods, Results, and Conclusions, unless specified otherwise in the reporting checklists), 200-350 words max. No abbreviations.

Key words: 3~5.

References: No limit.

Figures/Tables: No limit, but 10 figures are deemed sufficient.

Description: Original articles should take the following format: Introduction, Methods, Results, Discussion and/or Conclusions. Original articles must have originality and clinical impact.

Original articles should include a section describing the contribution made by each author to the manuscript. See the “3.4 Author Contributions” sections for details.

If a submitted article includes any data that are not publicly available, the authors are required to fill in a data-sharing statement form, which should be submitted along with their manuscript. If the article is accepted for publication, the Data Availability Statement (form) will be published online alongside the article. See the “3.7.2 Data Sharing Statement” section for details.

When a manuscript documents any experiment(s) involving human subjects or animals, the authors must indicate an ethical statement both in the methods section and the footnote. See the “3.7.5 Ethical Statement” section for details.

Please note that systematic review with meta-analysis will be categorized as Original Article.

……

更多详情:

https://aes.amegroups.com/pages/view/guidelines-for-authors


中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。